Reports
Sale
Global Custom Antibody Market Size, Share, Report, Forecast: By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others; By Services: Antibody Development, Others; By Source; By Application; By End User; Distribution Channel; Regional Analysis; Market Analysis; Supplier Landscape; 2024-2032
Global Custom Antibody Market Outlook
The global custom antibody market size was valued at USD 393.3 million in 2023, driven by rising demand for personalised medicine across the globe. The market is expected to grow at a CAGR of 12.7% during the forecast period of 2024-2032, with the values likely to rise from USD 443.1 million in 2024 to USD 1149.1 million by 2032.
Custom Antibody: Introduction
Custom antibodies are specifically designed for research or diagnostic purposes. It involves generating antibodies that target specific antigens of interest through immunizing an animal, mostly, a rabbit or a mouse. They can be tailored for various applications like western blotting, ELISA, flow cytometry and other lab techniques. Custom antibodies play a crucial role when the usual antibodies do not meet the needs for a research project.
Global Custom Antibody Market Analysis
The biopharmaceutical industry has seen significant growth in recent years. With focus on biologics, monoclonal antibodies, and personalized medicine to treat chronic diseases like cancer and autoimmune disorders, the custom antibody market demand has grown.
The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.
China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.
Global Custom Antibody Market Segmentation
Market Breakup by Product Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
Market Breakup by Services
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
- Others
Market Breakup by Source
- Mice
- Rabbit
- Others
Market Breakup by Application
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- CRO
- Hospitals and Clinics
- Others
Market Breakup by Distribution Channel
- Direct Tender
- Third Party Distributors
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Custom Antibody Market Overview
The United States has dominated the custom antibody market share globally. The market size can be accredited to a well-developed research infrastructure, along with the presence of influential pharmaceutical companies working seamlessly to develop more drugs and therapeutics. Moreover, the advent of artificial intelligence and digitally enabled tools is also helping to make the drug development processes rapid and precise.
In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.
The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.
Global Custom Antibody Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc.
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc.
- GenScript
- Agilent Technologies
- Proteogenix
- Raybiotech, Inc.
- ProSci Incorporated
- Innovagen AB
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Services |
|
| Breakup by Source |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Custom Antibody Market Overview
3.1 Global Custom Antibody Market Historical Value (2017-2023)
3.2 Global Custom Antibody Market Forecast Value (2024-2032)
4 Global Custom Antibody Market Landscape
4.1 Global Custom Antibody Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Custom Antibody Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Custom Antibody Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Custom Antibody Market Segmentation
6.1 Global Custom Antibody Market by Product Type
6.1.1 Market Overview
6.1.2 Monoclonal Antibodies
6.1.3 Polyclonal Antibodies
6.1.4 Recombinant Antibodies
6.1.5 Others
6.2 Global Custom Antibody Market by Services
6.2.1 Market Overview
6.2.2 Antibody Development
6.2.3 Antibody Production and Purification
6.2.4 Antibody Fragmentation and Labelling
6.2.5 Others
6.3 Global Custom Antibody Market by Source
6.3.1 Market Overview
6.3.2 Mice
6.3.3 Rabbit
6.3.4 Others
6.4 Global Custom Antibody Market by Application
6.4.1 Market Overview
6.4.2 Oncology
6.4.3 Infectious Diseases
6.4.4 Neurology
6.4.5 Stem Cells
6.4.6 Immunology
6.4.7 Cardiovascular Diseases
6.4.8 Others
6.5 Global Custom Antibody Market by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical and Biotechnology Companies
6.5.3 Academic and Research Institutes
6.5.4 CRO
6.5.5 Hospitals and Clinics
6.5.6 Others
6.6 Global Custom Antibody Market by Distribution Channel
6.6.1 Market Overview
6.6.2 Direct Tender
6.6.3 Third Party Distributors
6.6.4 Others
6.7 Global Custom Antibody Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Custom Antibody Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Custom Antibody Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Custom Antibody Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Custom Antibody Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Custom Antibody Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Creative Diagnostics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Abcam plc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Bio-Rad Laboratories, Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Kaneka Eurogentec S.A.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 YenZym Antibodies, LLC.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Abmart
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Labcorp Drug Development
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 LifeSpan BioSciences, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 GenScript
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Agilent Technologies
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Proteogenix
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Raybiotech, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 ProSci Incorporated
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Innovagen AB
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Custom Antibody Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 393.3 million in 2023, driven by the increasing prevalence of customised medicine across the globe.
The market is anticipated to grow at a CAGR of 12.7% during the forecast period of 2024-2032, likely to reach a market value of USD 1149.1 million by 2032.
The market demand is driven by the rising prevalence of chronic diseases as well as antibiotic resistance which requires new antibody-based drugs for effective treatment on patients.
The current market trend is around the expanding division of pharmaceutical companies to devise novel drugs and therapeutics. In August 2023, China based Biocytogen Pharmaceuticals Co. Ltd. launched two new divisions, focusing on animal models and preclinical services along with development and discovery of new antibody-based drugs.
Product types include monoclonal, polyclonal, and recombinant antibodies, among others.
Based on services, the market is divided into antibody development, antibody production and purification, antibody fragmentation and labelling, among others.
Mice and rabbit among others are the common sources.
Common application areas include oncology, infectious diseases, neurology, stem cells, immunology, and cardiovascular diseases, among others.
Major distribution channels include direct tender and third party distributors, among others.
Major end users include pharmaceutical, biotechnology companies, academic and research institutes, CRO, hospitals and clinics, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Thermo Fisher Scientific Inc., Creative Diagnostics, Abcam plc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., Abmart, Labcorp Drug Development, LifeSpan BioSciences, Inc., GenScript, Agilent Technologies, Proteogenix, Raybiotech, Inc., ProSci Incorporated, and Innovagen AB.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER